Challenge of an evolving organism: it is a moving target. While microbes evolve at an exponential rate, drug-development occurs at a much slower rate. It takes on an average 10 years and 1.4 billiondollars to develop one FDA approved drug. Pathogenes and time. Majority of pharmaceutical companies have moved out of the antiviral and antibiotic space due to lack of new classes of drugs, tedious, time-consuming, challenging discovery and development, evolution of drug-resistance, and low return on investment. Every time a new pathogen shows up, at present, collectively we as a human race are not capable of developing a new solution to solve it. The COVID-19 crisis has highlighted the need to be able to develop therapeutics in real-time. It is not possible to catch up to microbial evolution, unless we select for novel and innovative approaches, and create an ecosystem for fast-tracking of promising technologies. At ARC Labs we are developing a frame work for sustainable innovation.